Posted On: 03/31/2016 11:22:10 AM
Post# of 72447
Copied from Ihub, from Just 10-11-12:
FROM LEO: re--Dr J leaving
Thank you for being a shareholder of Cellceutix.
I wish to point out that Dr Jorgensen was not a director at Cellceutix. From the 8-K......
"Effective March 31, 2016, Daniel Jorgensen MD, a non-executive officer, will no longer serve as the Chief Medical Officer of Cellceutix Corporation."
In addition please note our press release...."We believe Cellceutix is now becoming so much more than an oncology or antibiotic drug company. And we expect to be a big part of the solution in developing better drugs for gastro-intestinal diseases and dermatology as well. A lot of good things are happening. The future is bright."
We will miss Dr. Jorgensen, but as he was not under contract, he must do what is best for him and his family.
Best wishes,
Leo Ehrlich | CEO |
FROM LEO: re--Dr J leaving
Thank you for being a shareholder of Cellceutix.
I wish to point out that Dr Jorgensen was not a director at Cellceutix. From the 8-K......
"Effective March 31, 2016, Daniel Jorgensen MD, a non-executive officer, will no longer serve as the Chief Medical Officer of Cellceutix Corporation."
In addition please note our press release...."We believe Cellceutix is now becoming so much more than an oncology or antibiotic drug company. And we expect to be a big part of the solution in developing better drugs for gastro-intestinal diseases and dermatology as well. A lot of good things are happening. The future is bright."
We will miss Dr. Jorgensen, but as he was not under contract, he must do what is best for him and his family.
Best wishes,
Leo Ehrlich | CEO |
(3)
(0)
